Glen Industries P/B Ratio
Current P/B Ratio
1.97
Moderate Valuation
Moderate - Reasonably valued relative to book value
Glen Industries P/B ratio. Glen Industries (GLEN) P/B ratio is 1.97 (Moderate), book value per share ₹43.75 vs Healthcare average P/B of -0.3 — Moderate - Reasonably valued relative to book value. Browse GLEN balance sheet details for revenue, profit, balance sheet and cash flow data.
Current Valuation Metrics
P/B Ratio
1.97
Current Price
₹
Book Value/Share
₹43.75
Exchange
None
Book Value Breakdown (2026)
Balance Sheet Components
Total Equity
₹140 Cr
Share Capital
₹32 Cr
Reserves & Surplus
₹107 Cr
Outstanding Shares
32,000,000
Book Value per Share
₹43.75
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
-0.3
Sector Median
0.39
Sector Rank
#11 of 50
Sector Percentile
22.0%
GLEN P/B Ratio — Valuation Insights & Book Value Analysis
Glen Industries price-to-book ratio interpretation, valuation status and historical context — current P/B 1.97 (Moderate). Read GLEN dividend track record for the complete payout history and dividend yield track record.
- Trading at premium to sector average PB of -0.3
GLEN vs Healthcare Peers — P/B Ratio Comparison
Glen Industries P/B 1.97 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.
Sector Average
-0.3
Sector Median
0.39
Lowest P/B
-7.62
Highest P/B
0.89
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Chennai Meenakshi Multis… | CMMHOSP | -7.62 | ₹27 | Low |
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹39 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.75 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹43 | Low |